Recordati Industria Chimica e Farmaceutica S.p.A. Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca PLC | Outperform |
17
|
£121.70 | £165.99 | 33.89% | 16 | £188.66B |
ABT | Abbott Laboratories | Outperform |
9
|
$106.29 | $118.92 | 19.01% | 7 | $184.43B |
PFE | Pfizer | Outperform |
2
|
$27.18 | $32.87 | 12.21% | 6 | $153.91B |
4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.14k | ¥4.74k | 9.82% | 0 | ¥6.50T |
ARGX | argenx | Outperform |
4
|
350.80€ | 531.81€ | 24.86% | 10 | 20.83€B |
GMAB | Genmab A/S | Outperform |
16
|
kr1.97k | kr2.71k | 33.81% | 14 | kr127.11B |
VTRS | Viatris Inc | Hold |
8
|
$11.63 | $11.73 | 3.18% | 5 | $13.74B |
IPN | Ipsen | Hold |
17
|
114.10€ | 127.95€ | 5.17% | 0 | 9.42€B |
CHDN | Churchill Downs | Buy |
16
|
$129.83 | $143.67 | 11.68% | 2 | $9.48B |
ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr630.00 | kr357.00 | 29.37% | 2 | kr39.42B |
ORNBV | Orion Oyj | Hold |
14
|
35.79€ | 42.52€ | 17.35% | 3 | 5.04€B |
HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.35 | £28.11 | 50.96% | 9 | £4.27B |
ALK B | ALK-Abelló A/S | Outperform |
13
|
kr131.20 | kr109.25 | 1.37% | 3 | kr28.87B |
ALRM | Alarm.com Holdings | Outperform |
16
|
$66.90 | $67.13 | 23.47% | 7 | $3.34B |
BHC | Bausch Health Companies | Hold |
15
|
$8.75 | $9.50 | 8.57% | 5 | $3.21B |
VIRP | Virbac | Outperform |
18
|
347.00€ | 348.34€ | 6.34% | 5 | 2.90€B |
MOR | MorphoSys | Outperform |
6
|
66.20€ | 28.78€ | 2.72% | 3 | 2.49€B |
PENN | PENN Entertainment | Outperform |
13
|
$16.44 | $29.89 | 52.07% | 1 | $2.52B |
INDV | Indivior PLC | Buy |
14
|
£14.28 | £28.89 | 118.77% | 4 | £1.95B |
CORT | Corcept Therapeutics | Buy |
16
|
$23.88 | $35.67 | 59.13% | 4 | $2.48B |
ALM | Almirall | Outperform |
16
|
8.57€ | 11.39€ | 28.35% | 3 | 1.79€B |
EVT | Evotec | Outperform |
14
|
9.74€ | 37.33€ | 161.81% | 4 | 1.73€B |
COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.30 | CHF76.55 | 29.41% | 0 | CHF1.16B |
FAE | Faes Farma | Hold |
18
|
3.41€ | 3.90€ | 7.04% | 0 | 1.06€B |
MERC | Mercer International | Hold |
14
|
$10.24 | $8.63 | 2.54% | 4 | $676.64M |
PHM | Pharma Mar | Outperform |
13
|
30.44€ | 50.20€ | 57.69% | 1 | 536.95€M |
SFA | Sopharma AD | Buy |
14
|
лв6.02 | лв6.96 | 18.60% | 0 | лв997.04M |
BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF39.50 | CHF65.63 | 67.09% | 0 | CHF474.13M |
XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.75 | $4.60 | 171.43% | 1 | $244.39M |
DBV | DBV Technologies | Outperform |
5
|
1.24€ | 4.07€ | 222.58% | 1 | 119.30€M |
MOLN | Molecular Partners | Outperform |
4
|
CHF3.29 | CHF9.50 | 184.19% | 1 | CHF110.77M |